Indica News
  • Home
  • News
    • Production
    • Pharma
    • Dispensaries
    • Investors
    • Sales and Operations
    • Consumer
    • Events and Networking
    • Politics and Law
  • Directory
    • Dashboard
  • Login or Register
  • Account
Select Page
South  Africa’s 1st cannabis business plots course for IPO within year

South Africa’s 1st cannabis business plots course for IPO within year

by InfluencER | Aug 30, 2021 | Pharma

Cilo Cybin Pharmaceutical Ltd. is considering an initial public offering in the next 12 months after becoming the first South African company to win the right to grow, process, and package cannabis products. The firm, named after the psychoactive substance in magic...
New Trial To Probe Cannabis-Based Treatments For Gynecologial Conditions

New Trial To Probe Cannabis-Based Treatments For Gynecologial Conditions

by InfluencER | Aug 27, 2021 | Pharma

New Israeli clinical trials will examine the safety and efficacy of cannabis-based treatments for some of the most painful and persistent gynecological conditions faced by women. The trials, expected in early 2022, will test cannabis-based pharmacology products...
South  Africa’s 1st cannabis business plots course for IPO within year

Cannabis company plans listing after being handed first rights to grow and package weed products in South Africa

by InfluencER | Aug 24, 2021 | Investors, Pharma

Cilo Cybin Pharmaceutical is considering an initial public offering in the next 12 months after becoming the first South African company to win the right to grow, process, and package cannabis products. The firm, named after the psychoactive substance in magic...
Panaxia and Neuraxpharm Expands Strategic Collaboration to Poland

Panaxia and Neuraxpharm Expands Strategic Collaboration to Poland

by InfluencER | Aug 20, 2021 | Pharma

Panaxia Labs Israel Ltd. (“Panaxia Israel”), (TASE: PNAX), a global pharma company, specializes in developing, manufacturing, and marketing advanced medical cannabis products in pharmaceutical quality and its partner, Neuraxpharm, Europe’s leading Pharma Company...
MediPharm Labs Receives Export Authorization to Ship Medical Cannabis to Brazil

MediPharm Labs Receives Export Authorization to Ship Medical Cannabis to Brazil

by InfluencER | Aug 19, 2021 | Pharma

MediPharm Labs Corp. (“MediPharm Labs” ) a pharmaceutical company that specializes in cannabis, is pleased to announce that it has received approval to ship medical cannabis oil to Brazil. This approval, issued by both ANVISA and Health Canada, allows initial...
Study Finds That Non-Pharmaceutical May Boost Quality Of Life Among Epilepsy Patients

Study Finds That Non-Pharmaceutical May Boost Quality Of Life Among Epilepsy Patients

by InfluencER | Aug 13, 2021 | Pharma

Patients who suffer from epilepsy, which affects some 3.4 million people across the United States, report experiencing improved quality of life and a more restful night’s sleep after consuming the non-psychoactive cannabinoid CBD (cannabidiol)....
« Older Entries
Next Entries »

Recent Posts

  • US Virgin Islands Governor Plans Marijuana Legalization Special Session And Puts Expected Revenue In Budget
  • North Carolina Senate Approves Medical Marijuana Legalization Bill
  • New York Senate Approves Bill To Mandate Medical Marijuana Health Insurance Coverage
  • Louisiana Widening Access to Medical Marijuana Law
  • Indiana lawmakers to discuss cannabis this summer

Archives

  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020

Categories

  • Consumer
  • Dispensaries
  • Events and Networking
  • General
  • Investors
  • Pharma
  • Politics and Law
  • Production
  • Sales and Operations
  • Facebook
  • X
  • Instagram
  • RSS
© Indica News | All Rights Reserved | info@indica.news | 1.833.450.9333